Literature DB >> 33125861

YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis.

Guoqiang Chang1, Lei Shi2, Youqiong Ye3, Hailing Shi4, Lixian Zeng2, Shweta Tiwary2, Jason T Huse5, Lei Huo5, Li Ma2, Yongjie Ma6, Sicong Zhang2, Jianwei Zhu2, Victoria Xie7, Peng Li1, Leng Han3, Chuan He8, Suyun Huang9.   

Abstract

Brain metastasis is a major cause of cancer mortality, but its molecular mechanisms are severely understudied. In addition, little is known regarding the role of m6A reader YTHDF3 in human diseases. Here, we show that YTHDF3 overexpression clinically correlates with brain metastases in breast cancer patients. YTHDF3 promotes cancer cell interactions with brain endothelial cells and astrocytes, blood-brain barrier extravasation, angiogenesis, and outgrow. Mechanistically, YTHDF3 enhances the translation of m6A-enriched transcripts for ST6GALNAC5, GJA1, and EGFR, all associated with brain metastasis. Furthermore, overexpression of YTHDF3 in brain metastases is attributed to increased gene copy number and the autoregulation of YTHDF3 cap-independent translation by binding to m6A residues within its own 5' UTR. Our work uncovers an essential role of YTHDF3 in controlling the interaction between cancer cells and brain microenvironment, thereby inducing brain metastatic competence.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  YTHDF3; brain metastasis; epigenetic regulation; gene amplification; m(6)A RNA methylation

Mesh:

Substances:

Year:  2020        PMID: 33125861      PMCID: PMC7738369          DOI: 10.1016/j.ccell.2020.10.004

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  73 in total

1.  Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes.

Authors:  Yu Pu; Xianfeng Lu; Xueqin Yang; Yi Yang; Dong Wang; Mengxia Li; Wei Guan; Mingfang Xu
Journal:  J Gastrointest Oncol       Date:  2022-02

2.  N6-Methyladenosine-Related Long Noncoding RNAs as Potential Prognosis Biomarkers for Endometrial Cancer.

Authors:  Rui Shi; Ziwei Wang; Jun Zhang; Zhicheng Yu; Lanfen An; Sitian Wei; Dilu Feng; Hongbo Wang
Journal:  Int J Gen Med       Date:  2021-11-16

3.  miR-151a-3p-rich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemness-enhancing niche.

Authors:  Bowen Li; Yiwen Xia; Jialun Lv; Weizhi Wang; Zhe Xuan; Cen Chen; Tianlu Jiang; Lang Fang; Linjun Wang; Zheng Li; Zhongyuan He; Qingya Li; Li Xie; Shengkui Qiu; Lu Zhang; Diancai Zhang; Hao Xu; Zekuan Xu
Journal:  Oncogene       Date:  2021-09-17       Impact factor: 9.867

4.  A signature based on m6A pattern and tumor microenvironment infiltration in clear cell renal cell carcinoma.

Authors:  Chen Yang; Tian Yu; Qingwen Li; Fang Xie; Qin Lin
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

5.  Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC.

Authors:  Haoming Wu; Jikun Feng; Jundong Wu; Wenjing Zhong; Xiazi Zouxu; Weiling Huang; Xinjian Huang; Jiarong Yi; Xi Wang
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-15       Impact factor: 4.322

6.  The m6A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation.

Authors:  Yangfan Xu; Xiaoyu He; Shanzheng Wang; Baofa Sun; Ruobing Jia; Peiwei Chai; Fang Li; Ying Yang; Shengfang Ge; Renbing Jia; Yun-Gui Yang; Xianqun Fan
Journal:  Oncogene       Date:  2022-02-03       Impact factor: 9.867

Review 7.  The roles of epigenetics in cancer progression and metastasis.

Authors:  Jocelyn F Chen; Qin Yan
Journal:  Biochem J       Date:  2021-09-17       Impact factor: 3.766

Review 8.  Regulatory Role of N6-methyladenosine (m6A) Modification in Osteosarcoma.

Authors:  Yujie Zhang; Yanyan Wang; Liwei Ying; Sifeng Tao; Mingmin Shi; Peng Lin; Yangxin Wang; Bin Han
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

Review 9.  The emerging role of RNA N6-methyladenosine methylation in breast cancer.

Authors:  Fangchao Zheng; Feng Du; Jiuda Zhao; Xue Wang; Yiran Si; Peng Jin; Haili Qian; Binghe Xu; Peng Yuan
Journal:  Biomark Res       Date:  2021-05-27

10.  N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation.

Authors:  Yuanming Cheng; Wei Xie; Brian F Pickering; Karen L Chu; Angela M Savino; Xuejing Yang; Hanzhi Luo; Diu Tt Nguyen; Shanlan Mo; Ersilia Barin; Anthony Velleca; Thomas M Rohwetter; Dinshaw J Patel; Samie R Jaffrey; Michael G Kharas
Journal:  Cancer Cell       Date:  2021-05-27       Impact factor: 38.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.